3205 Stock Overview
Researches, develops, and sells Chinese and western medicines, and health food products in Taiwan and Asia. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Sagittarius Life Science Corp Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$31.00 |
52 Week High | NT$52.90 |
52 Week Low | NT$30.80 |
Beta | 0.75 |
1 Month Change | -9.36% |
3 Month Change | -16.78% |
1 Year Change | -30.49% |
3 Year Change | 18.32% |
5 Year Change | -40.50% |
Change since IPO | -74.13% |
Recent News & Updates
Shareholder Returns
3205 | TW Personal Products | TW Market | |
---|---|---|---|
7D | -6.2% | -2.3% | -2.1% |
1Y | -30.5% | -21.1% | 25.6% |
Return vs Industry: 3205 underperformed the TW Personal Products industry which returned -21.1% over the past year.
Return vs Market: 3205 underperformed the TW Market which returned 25.6% over the past year.
Price Volatility
3205 volatility | |
---|---|
3205 Average Weekly Movement | 3.6% |
Personal Products Industry Average Movement | 4.2% |
Market Average Movement | 4.4% |
10% most volatile stocks in TW Market | 7.8% |
10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 3205 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 3205's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | n/a | n/a | www.naturalbiokey.com |
Sagittarius Life Science Corp researches, develops, and sells Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.
Sagittarius Life Science Corp Fundamentals Summary
3205 fundamental statistics | |
---|---|
Market cap | NT$1.01b |
Earnings (TTM) | -NT$59.00m |
Revenue (TTM) | NT$455.34m |
2.2x
P/S Ratio-17.1x
P/E RatioIs 3205 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3205 income statement (TTM) | |
---|---|
Revenue | NT$455.34m |
Cost of Revenue | NT$382.19m |
Gross Profit | NT$73.15m |
Other Expenses | NT$132.15m |
Earnings | -NT$59.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.81 |
Gross Margin | 16.06% |
Net Profit Margin | -12.96% |
Debt/Equity Ratio | 0% |
How did 3205 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 07:30 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sagittarius Life Science Corp is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|